Official Title
B Cell Responses in COVID-19: Generation of SARS-CoV-2 Neutralizing Human Monoclonal Antibodies to Efficiently Contrast Wild-type and Emerging Variants.
Brief Summary
In this study, we will develop techniques to optimize the in vitro production of humanmonoclonal antibodies.
Detailed Description
Not Provided
Active, not recruiting
COVID 19
Eligibility Criteria
Inclusion Criteria:
- Age >18 at time of signing informed consent form
- Signed informed consent form
Exclusion Criteria:
- Ongoing drug abuse
- Active or history of neoplastic malignancy
- Active autoimmune disease ongoing treatment with immunosuppressive therapy
- Ischemic heart disease
- Evidence of positive HIV, HCV, HBV test
- Diabetes
- Failure to sign informed consent form
Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 90 Years
Countries
Italy
Locations
Fondazione IRCCS Policlinico San Matteo di Pavia
Pavia, Italy
Not Provided
Fondazione IRCCS Policlinico San Matteo di Pavia
NCT Number
MeSH Terms
COVID-19